Neil R. Mucci
Neil R. Mucci is a biotech executive with over 25 years of strategic, operational, and commercial experience in biotechnology and clinical research. He has a successful track record of building, growing, and managing clinical research operations within multi-national biotech companies to support regulatory authority submission and product approval. Read more.
Mr. Mucci has supported Curetis GmbH as a Clinical Trial Consultant for validation of a multiplex PCR-based rapid pathogen detection diagnostic test. Mr. Mucci has served as the Head of Study Management at Epigenomics AG where he oversaw multiple clinical studies enrolling over 8,000 subjects for the validation of a blood-based molecular diagnostic colorectal cancer detection test.
He has worked with the United States National Cancer Institute (NCI) Office of Biorepositories and Biospecimen Research (OBBR) to develop the foundation for the Cancer Human BioBank (caHUB) and the Biospecimen Research Network (BRN) initiatives. Mr. Mucci has also supported the National Cancer Institute (NCI) with the Clinical Proteomics Tumor Analysis Consortium (CPTAC) Project and The Cancer Genome Atlas (TCGA) Project, as well as the National Human Genome Research Institute (NHGRI) with the Genome Tissue Expression (GTEx) Project.
Prior to Epigenomics, Mr. Mucci was a founder of the human tissue services company Asterand PLC where he served as Director of Laboratory Operations, Director of Quality Assurance, and Director of Strategic Alliances. At Asterand Mr. Mucci was responsible for establishing and managing clinical biospecimen collection programs at over 100 institutions in over 10 countries around the world.
Prior to joining Asterand, Mr. Mucci supervised the Prostate Cancer Tissue Core Facility at the University of Michigan Specialized Program of Research Excellence (UM Prostate SPORE) where he co-authored scientific articles on tissue procurement, tissue microarrays, surrogate end-point biomarker development, and telepathology.
Senior Clinical Research Manager
Jennifer Maas is a clinical research professional with over 15 years of experience from the healthcare and biotechnology industries with a focus on quality assurance, clinical research, and project management. Ms. Maas brings to GBC a firm commitment to quality, a level of efficiency that comes from operational experience, and a keen eye for detail. Read more.